RankingsPricing
  1. US-listed companies
  2. Elevance Health, Inc.
  3. Financials
  4. Capital expenditures

Elevance Health, Inc.ELV

Market cap
$81.1B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-1,256+9.03%
Dec 31, 2022-1,152+5.98%
Dec 31, 2021-1,087+6.46%
Dec 31, 2020-1,021-5.20%
Dec 31, 2019-1,077-10.84%
Dec 31, 2018-1,208+51.09%
Dec 31, 2017-799+36.99%
Dec 31, 2016-584-8.56%
Dec 31, 2015-638-10.69%
Dec 31, 2014-715+10.53%
Dec 31, 2013-646+24.45%
Dec 31, 2011-519+15.09%
Dec 31, 2010-451

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)